Levosimendan

Drug identity checked against registry records

Also recorded as Levosimendan 2.5 mg/mL Injectable Solution

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open-Label Rollover Study of Levosimendan in PH-HFpEF PatientsNCT03624010TENXPhase 2Completed2023-04-25Actual
Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEFNCT03541603TENXPhase 2Completed2020-04-07Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.